Global Respiratory Virus Trends: Current Status of Influenza and RSV

Global respiratory virus activity is following expected seasonal patterns as the Northern Hemisphere enters its winter months, according to the World Health Organization (WHO). While influenza and respiratory syncytial virus (RSV) remain the primary drivers of seasonal illness, surveillance data indicates that circulation levels are consistent with historical trends for this time of year, with ongoing monitoring by international health authorities to detect potential shifts in viral dominance.

How are influenza and RSV currently circulating?

The Centers for Disease Control and Prevention (CDC) reports that influenza activity in the United States is currently increasing, which is typical for the fall and winter seasons. Influenza A(H3N2) and A(H1N1)pdm09 are the predominant subtypes identified in recent laboratory samples. Simultaneously, RSV circulation is rising across multiple regions. Unlike influenza, which often peaks in mid-winter, RSV transmission patterns can vary, but the virus consistently causes significant respiratory burden in young children and older adults during the colder months.

What do current international surveillance data show?

According to the WHO Global Influenza Surveillance and Response System (GISRS), countries in the Northern Hemisphere are observing a steady uptick in respiratory illnesses. In contrast, the Southern Hemisphere is experiencing low, off-season levels of influenza. The WHO emphasizes that global surveillance is essential for identifying circulating strains, which informs the annual composition of the influenza vaccine. Current data suggests that the circulating influenza strains remain largely matched to the components included in the 2024-2025 Northern Hemisphere vaccine formulations.

Why is this season different from previous years?

Public health experts are focused on the “tripledemic” risk, a term used to describe the simultaneous circulation of influenza, RSV, and SARS-CoV-2. Following the COVID-19 pandemic, researchers have noted that viral seasonality became less predictable. However, the European Centre for Disease Prevention and Control (ECDC) notes that respiratory virus patterns are gradually returning to pre-pandemic norms. The introduction of new prophylactic tools, such as the maternal RSV vaccine and monoclonal antibody treatments for infants, has provided additional layers of protection that were not available during previous seasons.

How can you reduce your risk of respiratory infection?

Health authorities recommend several evidence-based strategies to minimize the impact of seasonal respiratory viruses:

• Vaccination: Staying up to date with annual influenza vaccines and updated COVID-19 boosters remains the most effective way to prevent severe disease.
• Hygiene Practices: Regular handwashing with soap and water for at least 20 seconds, or using an alcohol-based hand sanitizer, reduces the transmission of viral particles.
• Respiratory Etiquette: Covering coughs and sneezes and staying home when symptomatic prevents the spread of pathogens to vulnerable populations.
• Ventilation: Improving indoor air quality through better ventilation or the use of HEPA filters can decrease the concentration of airborne viruses in enclosed spaces.

While seasonal respiratory viruses are expected to remain active throughout the winter, the availability of vaccines and standardized surveillance systems allows for more effective management of these seasonal health challenges. Individuals should consult their primary care providers regarding their eligibility for specific immunizations, particularly those at higher risk for complications, such as the elderly and those with underlying chronic conditions.